NasdaqCM - Delayed Quote USD
Vivos Therapeutics, Inc. (VVOS)
At close: 4:00 PM EDT
After hours: 4:30 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.61 | -0.3 | -2.55 | -0.55 |
| Low Estimate | -0.61 | -0.3 | -2.55 | -0.55 |
| High Estimate | -0.61 | -0.3 | -2.55 | -0.55 |
| Year Ago EPS | -1.62 | -3.05 | -11.14 | -2.55 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 4.06M | 4.66M | 16.91M | 24.17M |
| Low Estimate | 4.06M | 4.66M | 16.91M | 24.17M |
| High Estimate | 4.06M | 4.66M | 16.91M | 24.17M |
| Year Ago Sales | 3.3M | 3.25M | 13.8M | 16.91M |
| Sales Growth (year/est) | 23.00% | 43.50% | 22.50% | 42.90% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -3.12 | -1.9 | -1.17 | -1.05 |
| EPS Actual | -1.62 | -3.05 | -1.63 | -0.6 |
| Difference | 1.5 | -1.15 | -0.46 | 0.45 |
| Surprise % | 48.10% | -60.50% | -39.30% | 42.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.61 | -0.3 | -2.55 | -0.55 |
| 7 Days Ago | -0.61 | -0.3 | -2.55 | -0.55 |
| 30 Days Ago | -0.78 | -0.58 | -3.34 | -1.78 |
| 60 Days Ago | -0.78 | -0.58 | -3.34 | -1.78 |
| 90 Days Ago | -0.96 | -0.87 | -4.14 | -3.02 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | VVOS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 62.30% | -- | -- | 4.50% |
| Next Qtr. | 90.20% | -- | -- | 9.60% |
| Current Year | 77.10% | -- | -- | 2.10% |
| Next Year | 78.40% | -- | -- | 12.90% |
| Next 5 Years (per annum) | -- | -- | -- | 11.76% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Ascendiant Capital: Buy to Buy | 8/20/2024 |
Related Tickers
NUWE Nuwellis, Inc.
1.8600
+13.41%
HSCS HeartSciences Inc.
3.0980
-4.38%
BBLG Bone Biologics Corporation
1.7300
+0.58%
RSLS ReShape Lifesciences Inc.
5.48
-3.35%
TNON Tenon Medical, Inc.
3.6200
-1.09%
NXL Nexalin Technology, Inc.
2.2900
+6.51%
BJDX Bluejay Diagnostics, Inc.
0.1053
+5.83%
BSGM BioSig Technologies, Inc.
0.8200
0.00%
VERO Venus Concept Inc.
0.4580
-4.38%
TIVC Tivic Health Systems, Inc.
0.3100
+3.37%